JP2022518288A5 - - Google Patents

Info

Publication number
JP2022518288A5
JP2022518288A5 JP2021543276A JP2021543276A JP2022518288A5 JP 2022518288 A5 JP2022518288 A5 JP 2022518288A5 JP 2021543276 A JP2021543276 A JP 2021543276A JP 2021543276 A JP2021543276 A JP 2021543276A JP 2022518288 A5 JP2022518288 A5 JP 2022518288A5
Authority
JP
Japan
Prior art keywords
polymorph
composition
pharmaceutical composition
approximately
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021543276A
Other languages
English (en)
Japanese (ja)
Other versions
JP7611148B2 (ja
JP2022518288A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/051528 external-priority patent/WO2020152226A1/en
Publication of JP2022518288A publication Critical patent/JP2022518288A/ja
Publication of JP2022518288A5 publication Critical patent/JP2022518288A5/ja
Priority to JP2024226332A priority Critical patent/JP2025036479A/ja
Application granted granted Critical
Publication of JP7611148B2 publication Critical patent/JP7611148B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021543276A 2019-01-23 2020-01-22 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物 Active JP7611148B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024226332A JP2025036479A (ja) 2019-01-23 2024-12-23 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19153315 2019-01-23
EP19153315.7 2019-01-23
PCT/EP2020/051528 WO2020152226A1 (en) 2019-01-23 2020-01-22 Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024226332A Division JP2025036479A (ja) 2019-01-23 2024-12-23 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物

Publications (3)

Publication Number Publication Date
JP2022518288A JP2022518288A (ja) 2022-03-14
JP2022518288A5 true JP2022518288A5 (https=) 2023-01-20
JP7611148B2 JP7611148B2 (ja) 2025-01-09

Family

ID=65228356

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021543276A Active JP7611148B2 (ja) 2019-01-23 2020-01-22 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物
JP2024226332A Pending JP2025036479A (ja) 2019-01-23 2024-12-23 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024226332A Pending JP2025036479A (ja) 2019-01-23 2024-12-23 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物

Country Status (17)

Country Link
US (1) US11891350B2 (https=)
EP (1) EP3860582B1 (https=)
JP (2) JP7611148B2 (https=)
KR (1) KR20210119403A (https=)
CN (1) CN113329746B (https=)
AU (1) AU2020210831B2 (https=)
BR (1) BR112021019476A2 (https=)
CA (1) CA3118996A1 (https=)
DK (1) DK3860582T3 (https=)
ES (1) ES2913977T3 (https=)
IL (1) IL282718B2 (https=)
PL (1) PL3860582T3 (https=)
PT (1) PT3860582T (https=)
RS (1) RS63270B1 (https=)
SG (1) SG11202111773QA (https=)
WO (1) WO2020152226A1 (https=)
ZA (1) ZA202107346B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3939578A1 (en) * 2020-07-13 2022-01-19 Novaremed Ltd. Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease
WO2026037478A1 (en) 2023-08-11 2026-02-19 Novaremed AG (s,s)-(3-o-(propan-2-ol)-2-amino-prop-1-yl-4-hydroxybenzene and its analogues for the treatment of chronic pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642290B2 (en) 2002-10-03 2010-01-05 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
JP4939396B2 (ja) * 2004-03-26 2012-05-23 ノヴァレメッド リミテッド Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
CN102821761B (zh) * 2009-09-09 2015-06-10 诺瓦麦有限公司 用于治疗疼痛和炎症的n-取代的苯丙酰胺或苯丙烯酰胺
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
GB0916073D0 (en) 2009-09-14 2009-10-28 Cintec Int Ltd Improvements in and relating to building anchor systems
AU2012348529B2 (en) 2011-12-08 2017-03-30 Novaremed Ltd. Isolated stereoisomeric forms of (S) 2-N (3-O-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide

Similar Documents

Publication Publication Date Title
KR102425226B1 (ko) Jak 저해제를 포함하는 제약 조성물
JP2023512175A5 (https=)
JP2023002662A5 (https=)
JP2019515884A5 (https=)
JP2022502500A5 (https=)
HU225887B1 (en) Process for producing pharmaceutical compositions containing flurbiprofen having painkiller activity
JP2010514806A5 (https=)
FI3856341T3 (fi) (s)-1-(4-fluorifenyyli)-1-(2-(4-(6-(1-metyyli-1h-pyratsol-4-yyli)pyrrolo[2,1-f][1,2,4]triatsin-4-yyli)piperatsinyyli)pyrimidin-5-yyli)etaani-1-amiinin kidemuotoja ja valmistusmenetelmiä
JP2022519744A5 (https=)
JP2009544585A5 (https=)
RU2003118411A (ru) Кристаллические производные 1-метилкарбапенема
JP2022523368A5 (https=)
JP2024507810A5 (https=)
JP2024544538A5 (https=)
KR20140099492A (ko) 삼환식 화합물, 이를 포함하는 조성물 및 그의 용도
JP2009513713A5 (https=)
JP2025508071A5 (https=)
EP4520394A3 (en) New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
JP2022518288A5 (https=)
JP2022507533A5 (https=)
JP2023500060A5 (https=)
JPH0681723B2 (ja) 非−白金抗癌薬によりひき起こされる嘔吐の軽減用治療剤
JP2022525202A5 (https=)
JP2023553253A5 (https=)
JP2019531286A5 (https=)